Media center
Press release
Absci and Owkin synergize leading TechBio platforms to advance generative AI drug discovery
Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class therapeutics.
January 10, 2025
Press release
Absci and Owkin synergize leading TechBio platforms to advance generative AI drug discovery
Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class therapeutics.
January 10, 2025
Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press release
Absci and Owkin synergize leading TechBio platforms to advance generative AI drug discovery
January 10, 2025
Absci and Owkin synergize leading TechBio platforms to advance generative AI drug discovery
January 10, 2025
Press release
Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare
December 12, 2024
Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare
December 12, 2024
Press release
Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients
November 19, 2024
Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients
November 19, 2024
Press release
Owkin announces MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer
October 29, 2024
Owkin announces MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer
October 29, 2024
Press release
Owkin announces partnership with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer
October 2, 2024
Owkin announces partnership with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer
October 2, 2024
Press release
IA et santé: l’AP-HP renouvelle son accord avec Owkin pour accélérer l'innovation IA au service des patients
September 26, 2024
IA et santé: l’AP-HP renouvelle son accord avec Owkin pour accélérer l'innovation IA au service des patients
September 26, 2024
Press release
Owkin collaborates with MSD to assess the impact of MSIntuit® CRC to accelerate patient identification for therapeutic decisions
August 19, 2024
Owkin collaborates with MSD to assess the impact of MSIntuit® CRC to accelerate patient identification for therapeutic decisions
August 19, 2024
Press release
Owkin and Finnish Biobanks collaborate to advance medical research
August 13, 2024
Owkin and Finnish Biobanks collaborate to advance medical research
August 13, 2024
Press release
Owkin's MSIntuit CRC wins Best Medical Technology Prix Galien Award
July 4, 2024
Owkin's MSIntuit CRC wins Best Medical Technology Prix Galien Award
July 4, 2024
Press release
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
May 23, 2024
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
May 23, 2024